Combining screening for lung and kidney cancers – for both of which smoking is a risk factor – could help identify ...
Lung cancer is one of the most common and aggressive cancers. Its most characteristic symptoms include coughing, shortness of ...
Emma Snape, 34, from Lancashire was given the heartbreaking diagnosis of an ultra-rare form of cancer that affects the cells ...
About 40% of Americans will develop a form of cancer at some point in their lifetime, according to the American Cancer ...
Lung cancer is one of the most common and aggressive cancers. Its most characteristic symptoms include coughing, shortness of ...
AstraZeneca's cancer drug, datopotamab deruxtecan, failed to meet targets in a Phase 3 trial, clouding the possibility of approval from the U.S. Food and Drug Administration. Shares were down 1.2% at ...
Amivantamab plus chemo is now indicated in locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R ...
AstraZeneca said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo did not significantly ...
Few companies have attracted more attention this year than Nvidia. The chipmaker is on a roll thanks to the rapid rise of ...
A recent study compared two dosages of ifinatamab deruxtecan among patients with extensive-stage small cell lung cancer.
The U.S. is one of only two countries that legally allows drugmakers to advertise products directly to patients. There are ...
NSCLC, adding nivolumab to tivozanib in metastatic RCC underwhelms, and T-DXd shows improvement in HER2+ breast cancer with brain metastases.